Related Experiment Video
Updated: Apr 14, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Dynamics of CDKL5 phosphorylation and its regulatory mechanisms in cultured cells
Syouichi Katayama1,2, Miwako Sakota2, Atsushi Morii3
1Division of Informatics, Bioengineering and Bioscience, Faculty of Engineering, Maebashi Institute of Technology, 460-1 Kamisadori, Maebashi, Gunma 371-0816, Japan.
Abstract:
Cyclin-dependent kinase-like 5 (CDKL5) is a serine/threonine protein kinase highly expressed in the brain, and mutations in its gene cause CDKL5 deficiency disorder (CDD). Although reports on CDKL5 substrate proteins are increasing, the phosphorylation-dependent regulation of CDKL5 function remains poorly understood. Therefore, in this study, we investigated the phosphorylation states of CDKL5 and explored the kinases and phosphatases involved in its regulation. The C-terminal region of exogenous CDKL5 was highly phosphorylated in Neuro2a neuroblastoma cells; endogenous CDKL5 in P19 embryonic carcinoma (P19EC) cells was also highly phosphorylated, mainly in the cytoplasm. CDKL5 underwent gradual dephosphorylation during aggregate formation in P19EC cells, and this process was suppressed by retinoic acid (RA), an inducer of neuronal differentiation. Okadaic acid treatment indicated that protein phosphatase 2A (PP2A) partially mediates CDKL5 dephosphorylation during aggregate formation. Kinase inhibitor screening and kinase assay in vitro demonstrated that multiple protein kinase C (PKC) isoforms contribute to CDKL5 phosphorylation. These findings suggest that CDKL5 phosphorylation is dynamically regulated by a balance between PKC and PP2A activities, and that RA signalling modulates this process during neuronal differentiation. Such phosphorylation mechanisms of CDKL5 may underlie the pathogenesis of CDD and help identify potential therapeutic targets.
Insights
Cyclin-dependent kinase-like 5 (CDKL5) phosphorylation is regulated by protein kinase C (PKC) and protein phosphatase 2A (PP2A). Retinoic acid (RA) signaling influences this balance during neuronal differentiation, impacting CDKL5 deficiency disorder (CDD) pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase-like 5 (CDKL5) is crucial for brain development, and its gene mutations cause CDKL5 deficiency disorder (CDD).
- The phosphorylation-dependent regulation of CDKL5 function is not well understood, despite increasing knowledge of its substrates.
Purpose of the Study:
- To investigate the phosphorylation status of CDKL5.
- To identify the specific kinases and phosphatases regulating CDKL5 phosphorylation.
- To explore the role of retinoic acid (RA) signaling in modulating CDKL5 phosphorylation during neuronal differentiation.
Main Methods:
- Investigated exogenous and endogenous CDKL5 phosphorylation in Neuro2a and P19 embryonic carcinoma (P19EC) cells.
- Utilized okadaic acid to assess the role of protein phosphatase 2A (PP2A) in CDKL5 dephosphorylation.
- Employed kinase inhibitor screening and in vitro kinase assays to identify contributing kinases, including protein kinase C (PKC) isoforms.
Main Results:
- Exogenous and endogenous CDKL5 were found to be highly phosphorylated, primarily in the cytoplasm.
- CDKL5 dephosphorylation occurred during P19EC cell aggregate formation and was inhibited by retinoic acid (RA).
- PP2A was identified as a key phosphatase in CDKL5 dephosphorylation, while multiple PKC isoforms were found to phosphorylate CDKL5.
Conclusions:
- CDKL5 phosphorylation is dynamically regulated by the interplay between PKC and PP2A activities.
- RA signaling modulates CDKL5 phosphorylation during neuronal differentiation, suggesting a link to CDD pathogenesis.
- Understanding these phosphorylation mechanisms may reveal therapeutic targets for CDD.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis

